NASDAQ:ENGN | Key Financial Ratios | enGene Therapeutics Inc.

Complete source-backed ratio history.

Available history
2022-10-31 to 2026-04-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-04-3012.57-41.25%-49.71%
2026-01-3111.75-36.32%-43.49%
2025-10-316.3-52.97%-69.94%
2025-07-3110.34-38.58%-47.20%
2025-04-3012.66-29.96%-35.14%
2025-01-3117.16-24.15%-27.62%
2024-10-3116.87-17.72%-20.23%
2024-07-3119.52-45.84%-53.12%
2024-04-3042.8-41.28%-46.47%
2024-01-3112.97-110.48%-165.44%
2023-10-3116.25-114.90%-137.84%
2022-10-314.42

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-10-316.3-52.97%-69.94%
2024-10-3116.87-17.72%-20.23%
2023-10-3116.25-114.90%-137.84%
2022-10-314.42-102.31%31.93%